Fatty acid metabolism, fatty-acid desaturase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 2 |
GO:0031090 | organelle membrane | 3 | 2 |
Related structures:
AlphaFold database: A0A3Q8IBJ0
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 16 |
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006631 | fatty acid metabolic process | 4 | 16 |
GO:0006633 | fatty acid biosynthetic process | 5 | 16 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 6 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0008610 | lipid biosynthetic process | 4 | 16 |
GO:0009058 | biosynthetic process | 2 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016053 | organic acid biosynthetic process | 4 | 16 |
GO:0019752 | carboxylic acid metabolic process | 5 | 16 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 16 |
GO:0033559 | unsaturated fatty acid metabolic process | 5 | 16 |
GO:0043436 | oxoacid metabolic process | 4 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 16 |
GO:0044255 | cellular lipid metabolic process | 3 | 16 |
GO:0044281 | small molecule metabolic process | 2 | 16 |
GO:0044283 | small molecule biosynthetic process | 3 | 16 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 16 |
GO:1901576 | organic substance biosynthetic process | 3 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0004768 | stearoyl-CoA 9-desaturase activity | 6 | 16 |
GO:0016215 | acyl-CoA desaturase activity | 5 | 16 |
GO:0016491 | oxidoreductase activity | 2 | 16 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 16 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4 | 16 |
GO:0005488 | binding | 1 | 6 |
GO:0005506 | iron ion binding | 6 | 2 |
GO:0043167 | ion binding | 2 | 6 |
GO:0043169 | cation binding | 3 | 6 |
GO:0046872 | metal ion binding | 4 | 6 |
GO:0046914 | transition metal ion binding | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 300 | 304 | PF00656 | 0.485 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 314 | 316 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 348 | 350 | PF00675 | 0.353 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.439 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.205 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 308 | 312 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.317 |
CLV_PCSK_SKI1_1 | 397 | 401 | PF00082 | 0.268 |
CLV_PCSK_SKI1_1 | 422 | 426 | PF00082 | 0.226 |
CLV_PCSK_SKI1_1 | 427 | 431 | PF00082 | 0.353 |
CLV_PCSK_SKI1_1 | 9 | 13 | PF00082 | 0.439 |
DOC_CKS1_1 | 295 | 300 | PF01111 | 0.497 |
DOC_CYCLIN_RxL_1 | 305 | 314 | PF00134 | 0.616 |
DOC_CYCLIN_yCln2_LP_2 | 328 | 334 | PF00134 | 0.580 |
DOC_MAPK_MEF2A_6 | 324 | 332 | PF00069 | 0.598 |
DOC_PP1_RVXF_1 | 206 | 212 | PF00149 | 0.250 |
DOC_PP1_RVXF_1 | 281 | 288 | PF00149 | 0.454 |
DOC_PP1_RVXF_1 | 374 | 381 | PF00149 | 0.560 |
DOC_PP2B_LxvP_1 | 328 | 331 | PF13499 | 0.570 |
DOC_PP2B_LxvP_1 | 37 | 40 | PF13499 | 0.304 |
DOC_USP7_UBL2_3 | 172 | 176 | PF12436 | 0.486 |
DOC_USP7_UBL2_3 | 308 | 312 | PF12436 | 0.510 |
DOC_WW_Pin1_4 | 294 | 299 | PF00397 | 0.462 |
LIG_14-3-3_CanoR_1 | 237 | 245 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 283 | 288 | PF00244 | 0.583 |
LIG_14-3-3_CanoR_1 | 349 | 354 | PF00244 | 0.446 |
LIG_14-3-3_CanoR_1 | 80 | 87 | PF00244 | 0.463 |
LIG_Actin_WH2_2 | 414 | 429 | PF00022 | 0.502 |
LIG_BRCT_BRCA1_1 | 89 | 93 | PF00533 | 0.502 |
LIG_deltaCOP1_diTrp_1 | 196 | 202 | PF00928 | 0.259 |
LIG_deltaCOP1_diTrp_1 | 335 | 338 | PF00928 | 0.523 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.234 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.431 |
LIG_FHA_1 | 402 | 408 | PF00498 | 0.463 |
LIG_FHA_1 | 59 | 65 | PF00498 | 0.287 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.457 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.560 |
LIG_FHA_2 | 248 | 254 | PF00498 | 0.456 |
LIG_FHA_2 | 295 | 301 | PF00498 | 0.505 |
LIG_FHA_2 | 321 | 327 | PF00498 | 0.569 |
LIG_LIR_Gen_1 | 149 | 158 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 160 | 169 | PF02991 | 0.437 |
LIG_LIR_Gen_1 | 225 | 234 | PF02991 | 0.568 |
LIG_LIR_Gen_1 | 253 | 263 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 28 | 39 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 303 | 311 | PF02991 | 0.551 |
LIG_LIR_Gen_1 | 335 | 346 | PF02991 | 0.525 |
LIG_LIR_Gen_1 | 75 | 82 | PF02991 | 0.249 |
LIG_LIR_Gen_1 | 90 | 100 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 149 | 153 | PF02991 | 0.451 |
LIG_LIR_Nem_3 | 160 | 166 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 225 | 231 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 253 | 258 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 28 | 34 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 335 | 341 | PF02991 | 0.509 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 90 | 96 | PF02991 | 0.502 |
LIG_PCNA_yPIPBox_3 | 349 | 362 | PF02747 | 0.542 |
LIG_Pex14_1 | 197 | 201 | PF04695 | 0.246 |
LIG_Pex14_1 | 95 | 99 | PF04695 | 0.459 |
LIG_Pex14_2 | 258 | 262 | PF04695 | 0.440 |
LIG_REV1ctd_RIR_1 | 172 | 180 | PF16727 | 0.419 |
LIG_SH2_CRK | 150 | 154 | PF00017 | 0.452 |
LIG_SH2_CRK | 163 | 167 | PF00017 | 0.445 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.254 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.459 |
LIG_SH2_GRB2like | 255 | 258 | PF00017 | 0.446 |
LIG_SH2_GRB2like | 381 | 384 | PF00017 | 0.498 |
LIG_SH2_PTP2 | 31 | 34 | PF00017 | 0.366 |
LIG_SH2_SRC | 22 | 25 | PF00017 | 0.644 |
LIG_SH2_SRC | 408 | 411 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 203 | 207 | PF00017 | 0.250 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.475 |
LIG_SH2_STAT3 | 130 | 133 | PF00017 | 0.447 |
LIG_SH2_STAT3 | 165 | 168 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 165 | 168 | PF00017 | 0.551 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.249 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 371 | 374 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 417 | 420 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.502 |
LIG_SH3_3 | 180 | 186 | PF00018 | 0.307 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.490 |
LIG_SUMO_SIM_anti_2 | 357 | 364 | PF11976 | 0.545 |
LIG_TRAF2_1 | 21 | 24 | PF00917 | 0.568 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.502 |
LIG_TYR_ITIM | 76 | 81 | PF00017 | 0.273 |
LIG_UBA3_1 | 390 | 397 | PF00899 | 0.459 |
LIG_WRC_WIRS_1 | 248 | 253 | PF05994 | 0.437 |
MOD_CDK_SPK_2 | 294 | 299 | PF00069 | 0.428 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.419 |
MOD_CK1_1 | 364 | 370 | PF00069 | 0.539 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.459 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.600 |
MOD_CK2_1 | 247 | 253 | PF00069 | 0.407 |
MOD_CMANNOS | 194 | 197 | PF00535 | 0.431 |
MOD_Cter_Amidation | 347 | 350 | PF01082 | 0.350 |
MOD_GlcNHglycan | 106 | 110 | PF01048 | 0.220 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.234 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.341 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.481 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.306 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.461 |
MOD_GSK3_1 | 330 | 337 | PF00069 | 0.506 |
MOD_GSK3_1 | 397 | 404 | PF00069 | 0.471 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.508 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.601 |
MOD_N-GLC_1 | 232 | 237 | PF02516 | 0.230 |
MOD_N-GLC_2 | 69 | 71 | PF02516 | 0.366 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.448 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.446 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.320 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.582 |
MOD_NEK2_1 | 361 | 366 | PF00069 | 0.566 |
MOD_NEK2_1 | 72 | 77 | PF00069 | 0.341 |
MOD_PKA_1 | 349 | 355 | PF00069 | 0.451 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.435 |
MOD_Plk_1 | 148 | 154 | PF00069 | 0.502 |
MOD_Plk_1 | 334 | 340 | PF00069 | 0.514 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.516 |
MOD_Plk_4 | 184 | 190 | PF00069 | 0.258 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.281 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.456 |
MOD_Plk_4 | 283 | 289 | PF00069 | 0.628 |
MOD_Plk_4 | 349 | 355 | PF00069 | 0.476 |
MOD_Plk_4 | 413 | 419 | PF00069 | 0.443 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.209 |
MOD_ProDKin_1 | 294 | 300 | PF00069 | 0.465 |
TRG_ENDOCYTIC_2 | 150 | 153 | PF00928 | 0.479 |
TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.256 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.446 |
TRG_NLS_MonoExtC_3 | 311 | 316 | PF00514 | 0.479 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCI5 | Leptomonas seymouri | 84% | 100% |
A0A0S4KNP4 | Bodo saltans | 59% | 97% |
A0A1X0NW01 | Trypanosomatidae | 65% | 100% |
A0A3Q8I9W7 | Leishmania donovani | 46% | 100% |
A0A3R7MEL0 | Trypanosoma rangeli | 66% | 100% |
A4H6I1 | Leishmania braziliensis | 46% | 100% |
A4HDT6 | Leishmania braziliensis | 93% | 100% |
A4HVZ3 | Leishmania infantum | 46% | 100% |
A4I134 | Leishmania infantum | 100% | 100% |
B7SB91 | Acheta domesticus | 30% | 100% |
C9ZW73 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9APP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 47% | 100% |
E9AX71 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
G5ED44 | Caenorhabditis elegans | 32% | 100% |
G5EGH6 | Caenorhabditis elegans | 32% | 100% |
O00767 | Homo sapiens | 30% | 100% |
O02858 | Sus scrofa | 29% | 100% |
O44390 | Trichoplusia ni | 31% | 100% |
O62849 | Ovis aries | 29% | 100% |
O65797 | Arabidopsis thaliana | 26% | 100% |
O94523 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 41% | 90% |
P13011 | Mus musculus | 28% | 100% |
P21147 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 39% | 85% |
Q12618 | Ajellomyces capsulatus | 39% | 91% |
Q4QAA5 | Leishmania major | 97% | 100% |
Q4QFT4 | Leishmania major | 46% | 100% |
Q64420 | Mesocricetus auratus | 27% | 100% |
Q6P7B9 | Rattus norvegicus | 29% | 100% |
Q6US81 | Spodoptera littoralis | 32% | 100% |
Q95MI7 | Capra hircus | 29% | 100% |
Q99PL7 | Mus musculus | 30% | 100% |
Q9FPD5 | Arabidopsis thaliana | 26% | 100% |
Q9LMI3 | Arabidopsis thaliana | 25% | 100% |
Q9LVZ3 | Arabidopsis thaliana | 27% | 100% |
Q9SID2 | Arabidopsis thaliana | 29% | 100% |
Q9TT94 | Bos taurus | 28% | 100% |